神经性厌食症恢复路径:皮层厚度减少与5-羟色胺转运体表达的交叉
本研究比较114例神经性厌食症患者与114名年龄匹配健康对照的皮层厚度改变,并分析其与神经递质受体、转运体及葡萄糖代谢空间分布的关系。结果显示,皮层变薄区域与AChN受体密度和葡萄糖代谢升高相关,而HT1a和SERT密度较高区域皮层相对保留;个体在这些区域变薄者抑郁和体像不满更重且30天增重更少。
要点
- AN患者皮层变薄区域与AChN受体密度及葡萄糖代谢升高相关。
- HT1a和SERT密度较高区域皮层相对保留,但个体变薄者症状更重、增重更少。
- 上述关联可能有助于定义AN的生物学风险特征,用于治疗分层。
核心结论
- AN患者皮层厚度改变与神经递质受体、转运体及葡萄糖代谢的空间分布相关,个体差异与症状严重度和早期增重有关。
研究设计与样本
- 研究纳入114例AN患者与114名年龄匹配健康对照(年龄范围12-29岁),基于健康个体PET结合研究数据(neuromaps)评估化疗结构,并在外部样本重复组水平结果。
主要发现
- 组水平上,AN患者皮层显著变薄区域与较高AChN受体密度和较高葡萄糖代谢摄取相关。
- 组水平上,HT1a和SERT密度较高区域皮层厚度相对保留。
- 个体水平上,这些区域出现皮层变薄的参与者报告更严重的抑郁和体像不满症状,且治疗相关增重较少。
临床怎么用
- 皮层厚度与化疗结构的关联可能辅助识别AN的生物学风险特征,为治疗分层和个体化提供线索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Severe reductions in the brain's cortical gray matter thickness (CT) have repeatedly been reported in anorexia nervosa (AN). The underlying mechanisms of these drastic changes remain unclear. Associations with potential underlying neurochemical and metabolic features have not been evaluated. In this study, we investigated whether CT alterations, across the cortical surface, in AN (n = 114) compared to healthy controls (HC; n = 114 age-matched, range 12-29 years old) might be associated with the spatial distribution of neurotransmitter receptors, transporters and/or metabolic glucose uptake (i.e., "chemoarchitecture", based on data from PET binding studies in healthy individuals, as implemented by neuromaps). First, the correlation between CT alterations in AN and chemoarchitecture was evaluated at the group-level. Second, chemoarchitecture was leveraged to compute per-participant correlations of neuroreceptor maps with CT alterations at the individual-level. Correlations with psychiatric symptoms and associations with early weight gain (30-days after admission) were tested. Group-level results were replicated in an external sample. Regions showing substantial cortical thinning in AN were also characterized by higher AChN receptor density and higher glucose metabolism uptake. While CT was comparatively preserved in AN at the group-level in regions with higher HT1a and SERT receptor density, individual participants who exhibited cortical thinning in these regions also reported more severe symptoms (depression and body dissatisfaction) and showed less treatment-related weight gain. These associations may help to define a biological risk signature for AN, possibly allowing for future applications in treatment stratification and/or personalization.
引用
- Tarchi L, Doose A, Bernardoni F, et al. Mapping the path to recovery: the intersection of cortical thickness reductions and serotonin transporter expression in anorexia nervosa. Mol Psychiatry. 2025. PMID: 41318670. doi:10.1038/s41380-025-03306-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。